Ferroptosis, a unique form of cell death characterized by iron-dependent lipid peroxidation, has gained significant attention as a potential target for eradicating therapy-resistant tumors. Recent studies have identified the flavoprotein ferroptosis suppressor protein 1 (FSP1) as a crucial regulator of ferroptosis, alongside glutathione peroxidase-4 (GPX4). FSP1, an NADP(H)-dependent oxidoreductase enzyme, plays a protective role by reducing lipophilic radical-trapping molecules (such as coenzyme Q, vitamin E, and vitamin K) to prevent uncontrolled lipid peroxidation. In the present study, we employed CRISPR-Cas9-based screens using an FSP1-dependent cellular model to identify novel metabolic pathways essential for FSP1 function. Our findings establish vitamin B₂ (riboflavin) as a key modulator of the FSP1-antioxidant recycling pathway and reveal a previously unrecognized link between vitamin B2 metabolism and ferroptosis. Furthermore, we propose a rational strategy to target these pathways and sensitize cancer cells to ferroptosis, with implications for understanding the interaction between nutrients and their contributions to cellular antioxidant capacity.
Vera Skafar (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: